NYSE · Medical - Healthcare Information Services

Veeva Systems Inc. (VEEV) Stock

$296.13 +3.96% NYSE: VEEV Healthcare

Valuation

MetricValue
Price$296.13
Market Cap$48.10B
P/E Ratio44.86
P/B Ratio6.09
P/S Ratio13.09
EPS (TTM)$5.44
52-Week High$310.50
52-Week Low$148.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE14.00%
ROA11.20%
ROCE13.61%
Gross Margin28.67%
Operating Margin28.67%
Net Margin29.34%
Debt/Equity0.02
Current Ratio4.89

Annual Financials (USD)

Metric20222023202420252026
Revenue$1.9B$2.2B$2.4B$2.7B$3.2B
Operating Profit$505.0M$459.0M$429.0M$691.0M$916.0M
Net Profit$427.0M$488.0M$526.0M$714.0M$909.0M
EPS$2.63$3.00$3.22$4.32$5.44
Op Margin27.3%21.3%18.2%25.2%28.7%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$3.8B$4.8B$5.9B$7.3B$9.0B
Total Liabilities$905.0M$1.1B$1.3B$1.5B$1.8B
Cash$1.1B$886.0M$703.0M$1.1B$1.4B
Borrowings$55.0M$61.0M$56.0M$76.0M$96.0M

Latest News

Veeva Systems (VEEV) Could Be 41% Undervalued Following Russell Index Removal Simply Wall St. · Jul 10, 2026 Veeva Systems (VEEV) Launches Veeva EHS For Manufacturing And Testing Teams Simply Wall St. · Jul 9, 2026 2 Reasons to Watch VEEV and 1 to Stay Cautious StockStory · Jul 9, 2026 Veeva Systems (VEEV) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks · Jul 8, 2026 Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know Zacks · Jul 8, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$764.0M$780.0M$911.0M$1.1B$1.4B
Investing Cash Flow$-360.0M$-1.0B$-1.1B$-721.0M$-1.1B
Financing Cash Flow$-55.0M$-63.0M$-79.0M$-79.0M$-263.0M
Net Cash Flow$410.0M$-252.0M$-183.0M$414.0M$302.0M
Free Cash Flow$750.0M$767.0M$885.0M$1.1B$1.4B

Valuation & Return Ratios

MetricValue
PEG Ratio1.82
EV / EBITDA31.74
FCF Yield3.63%
Quick Ratio5.46
Interest Coverage0.00
Return 1Y-0.78%
Return 3Y38.46%
Return 5Y0.43%

Ownership

Insiders Held8.59%
Institutions Held89.64%
Institutions Float Held98.06%
Institutional HolderSharesReport Date
Blackrock Inc.11,558,8752026-03-31
Vanguard Portfolio Management LLC7,376,0312026-03-31
Vanguard Capital Management LLC6,670,3182026-03-31
Alliancebernstein L.P.6,271,0982026-03-31
Linonia Partnership LP4,924,6262026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Veeva Systems Inc.

Veeva Systems Inc. is led by CEO Peter Gassner, employs 7,291 people, headquartered in Pleasanton, US, publicly traded since 2013.

Veeva Systems Inc. (VEEV) stock trades at $296.13 with a market capitalization of $48.10B. The stock is valued at a price-to-earnings (P/E) ratio of 44.86, price-to-book of 6.09, price-to-sales of 13.09. Over the past 52 weeks the stock has ranged between $148.05 and $310.50, and currently trades 4.6% below its 52-week high.

On profitability, Veeva Systems Inc. generates a return on equity (ROE) of 14.00%, above the typical market average, return on capital employed of 13.61%, an operating margin of 28.67%, a net profit margin of 29.34%.

In its most recent fiscal year, Veeva Systems Inc. reported annual revenue of $3.2B, net profit of $909.0M, revenue has compounded at 16.9% a year over the last five years, profit at 19.1% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.02 — a conservative balance sheet with little leverage risk, a current ratio of 4.89, total assets of $9.0B, $1.4B in cash and equivalents.

VEEV has a beta of 0.97.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides